# Via Negativa for AI Alignment: Why Negative Constraints Are Structurally Superior to Positive Preferences

Preprint · Quan Cheng

- Archive id: arxiv:2603.16417
- Published: 2026-03-17
- arXiv: https://arxiv.org/abs/2603.16417
- Source URL: https://arxiv.org/abs/2603.16417
- PDF: https://arxiv.org/pdf/2603.16417
- Provenance: arxiv

## Abstract

Recent empirical results have demonstrated that training large language models (LLMs) with negative-only feedback can match or exceed standard reinforcement learning from human feedback (RLHF). Negative Sample Reinforcement achieves parity with PPO on mathematical reasoning; Distributional Dispreference Optimization trains effectively using only dispreferred samples; and Constitutional AI outperforms pure RLHF on harmlessness benchmarks. Yet no unified theoretical account explains why negative signals are so effective. This paper proposes such an account: positive preferences and negative constraints are structurally asymmetric. Positive preferences ("which is better") encode continuously coupled, context-dependent human values that cannot be exhaustively specified -- leading models to learn surface correlates such as agreement with the user (sycophancy). Negative constraints ("what is wrong") encode discrete, finite, independently verifiable prohibitions that can converge to a stable boundary. This asymmetry -- rooted in Popper's falsification logic and the epistemology of negative knowledge -- explains both the sycophancy failure of preference-based RLHF and the surprising effectiveness of negative-signal methods. We argue that alignment research should shift its center of gravity from "learning what humans prefer" to "learning what humans reject," and offer testable predictions for this framework.

_Abstract reproduced under CC0-1.0 (arXiv descriptive metadata)._

---
Space Kitty Archive · https://space-kitty.com · API: https://space-kitty.com/api/v1 · MCP: https://space-kitty.com/mcp · Premium: $0.20/request via x402 (Base Sepolia (testnet)). Metadata: arXiv (CC0), OpenAlex (CC0), Europe PMC (CC BY/CC0 works), ClinicalTrials.gov.